PTSD, AUD, and Interpersonal Conflict: Within-person Associations

Sponsor
University of South Dakota (Other)
Overall Status
Recruiting
CT.gov ID
NCT04552782
Collaborator
National Institute of Mental Health (NIMH) (NIH), Sioux Falls VA Health Care System (U.S. Fed), Bay Pines VA Healthcare System (U.S. Fed)
250
3
4
52.8
83.3
1.6

Study Details

Study Description

Brief Summary

The present study seeks to increase understanding of Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD) among veterans, an important public health concern. We will study the effects of regulatory deficits and sleep disturbance on the dynamic course of PTSD and AUD. The study will investigate whether a short, computerized training in the laboratory will alter maladaptive response biases and reduce associations between sleep disturbance, affect and behavioral dysregulation, AUD symptoms, and PTSD symptoms in the real world.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Alcohol CBM
  • Behavioral: PTSD CBM
  • Behavioral: Alcohol Sham
  • Behavioral: PTSD Sham
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
PTSD, AUD, and Interpersonal Conflict: Within-person Associations
Actual Study Start Date :
Dec 4, 2020
Anticipated Primary Completion Date :
Apr 30, 2025
Anticipated Study Completion Date :
Apr 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Alcohol Cognitive Bias Modification (CBM) + PTSD CBM

Behavioral: Alcohol CBM
Trains approach or avoidance responses to alcohol cues.

Behavioral: PTSD CBM
Trains approach or avoidance responses to trauma cues.

Experimental: Alcohol CBM + PTSD Sham

Behavioral: Alcohol CBM
Trains approach or avoidance responses to alcohol cues.

Behavioral: PTSD Sham
Will not train approach or avoidance responses.

Experimental: Alcohol Sham + PTSD CBM

Behavioral: PTSD CBM
Trains approach or avoidance responses to trauma cues.

Behavioral: Alcohol Sham
Will not train approach or avoidance responses.

Sham Comparator: Alcohol Sham + PTSD Sham

Behavioral: Alcohol Sham
Will not train approach or avoidance responses.

Behavioral: PTSD Sham
Will not train approach or avoidance responses.

Outcome Measures

Primary Outcome Measures

  1. Rate of Alcohol Use Disorder Symptoms [2 years]

    These are experience sampling items derived from Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

  2. Rate of PTSD Symptoms [2 years]

    These are experience sampling items derived from the PTSD Checklist from DSM-5 (PCL-5).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • OIF/OEF/OND veterans

  • At risk for PTSD (i.e., PCL-5 ≥33) and/or AUD (i.e., AUDIT ≥ 7 (women) ≥ 8 (men))

Exclusion Criteria:
  • Psychosis or severe Alcohol Use Disorder that contraindicates participation (based on interview)

  • Active suicidal or homicidal ideation that contraindicates participation (based on interview)

  • Severe risk for sleep apnea (a positive score in three categories of the Berlin Questionnaire), or reported treatment for sleep apnea

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bay Pines VA Health Care System Bay Pines Florida United States 33744
2 Sioux Falls VA Health Care System Sioux Falls South Dakota United States 57105
3 The University of South Dakota Vermillion South Dakota United States 57069

Sponsors and Collaborators

  • University of South Dakota
  • National Institute of Mental Health (NIMH)
  • Sioux Falls VA Health Care System
  • Bay Pines VA Healthcare System

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of South Dakota
ClinicalTrials.gov Identifier:
NCT04552782
Other Study ID Numbers:
  • 1R01MH122954
First Posted:
Sep 17, 2020
Last Update Posted:
May 24, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 24, 2022